-
Hybribio Victory laboratory combats COVID-19 epidemic in Tibet
Recently, there has been a number of clustered epidemics in Shigatse, Tibet, with a tendency of quick spreading. Answering the calling from Shanxi Province's special office for COVID-19 epidemic c
2022-09-06 古天乐代言太阳集团 56
-
Hybribio listed in ‘T0P 20 China Medical Device Enterprises’ with shining innovation
On July 12, the China Pharmaceutical and Health Industry Symbiosis Conference was held in Huzhou, Zhejiang Province, hosted by Guangzhou JD Pharmaceutical Information Co. At the conference and under t
2022-07-30 古天乐代言太阳集团 153
-
Carrying forward "Spirit of Hong Kong", Hybribio completed COVID-19 nucleic acid testing task for 25th anniversary of Hong Kong's return to motherland
On July 1st, Hong Kong celebrated the 25th anniversary of the reunification with the motherland and the inaugural ceremony of the sixth-term government of the Hong Kong Special Administrative Region.
2022-07-15 古天乐代言太阳集团 265
-
Hybribio HPV assays passed 2021 WHO HPV LabNet with highest scores
Global HPV DNA PP 2021 technical report, a summary report of WHO HPV evaluation, was released recently. The WHO HPV LabNet evaluated Hybribio 37 HPV GenoArray Diagnostic Kit, 23 HPV Genotyping Real
2022-06-15 古天乐代言太阳集团 172
-
Hybribio Monkeypox Virus Real-time PCR Kit and Methylation Real-time PCR Kit received CE approval
Hybribio Monkeypox Virus Nucleic Acid Test, SOX1 and PAX1 Methylation Real-time PCR Kit, and SOX1-OT and HIST1H4F Methylation Real-time PCR Kit recently met the compliance requirements of the EU medic
2022-06-01 古天乐代言太阳集团 358
-
Hybribio Beijing medical lab receives thank-you letter for Covid-19 testing work in Beijing Winter Olympics
The 2022 winter Olympics and the Paralympics were equally breathtaking, which brought an exciting ice and snow competition to the world. Olympic athletes stepped on ice skates and snowboards, galloped
2022-03-31 古天乐代言太阳集团 63